Thursday, May 15, 2025
Home > COVID19 (Page 7)

NVAX Stock Rises 7%, Novavax Starts Late-Stage Covid-19 Vaccine Trials

Following the news about the progress with COVID-19 vaccine trials, Novavax shares which closed 0.86% higher on Thursday gained more than 7.33% in the pre-market.American vaccine development company Novavax Inc (NASDAQ: NVAX) has revealed that it has commenced its late-large COVID-19 vaccine trials in the United Kingdom stirring a rise

Read More

MRNA Stock Up 1%, Moderna to Confirm Efficacy of COVID-19 Vaccine by November

Moderna COVID-19 vaccine candidate dubbed mRNA-1273 has entered its late-stage trials. The company noted that as of Wednesday, September 16, 2020, about 25,296 participants have been enrolled.The CEO of biotechnology company Moderna Inc (NASDAQ: MRNA) Stephane Bancel has disclosed the company will know whether its COVID-19 vaccine candidate will be

Read More

AstraZeneca Resumes Trials for COVID-19 Vaccine, AZN Stock Slightly Up

In partnership with U.K.’s Oxford University, AstraZeneca said that it will resume the phase three clinical trial for its COVID-19 vaccine contender AZD1222 since it got an approval from UK’s Medicines Health Regulatory Authority. After pausing its work on the coronavirus vaccine citing safety concerns last week, pharmaceutical giant AstraZeneca plc

Read More

A Blockchain company in Seoul may be ground zero for a fresh resurgence of COVID-19

According to Asia Kyungjae, at least 44 employees of an unnamed South Korean Blockchain company recently tested positive for COVID-19. The employees have since been quarantined.The report states that the company is based in the southern Gwanak District of Seoul; a well-known hub for large tech companies. Some are concerned

Read More